nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—Obstructive airways disorder—Hydrochlorothiazide—nephrolithiasis	0.0213	0.0399	CcSEcCtD
Pramipexole—SLC22A2—nephron—nephrolithiasis	0.021	0.301	CbGeAlD
Pramipexole—Localised oedema—Hydrochlorothiazide—nephrolithiasis	0.0191	0.0358	CcSEcCtD
Pramipexole—Shoulder pain—Hydrochlorothiazide—nephrolithiasis	0.0179	0.0336	CcSEcCtD
Pramipexole—Atrioventricular block second degree—Hydrochlorothiazide—nephrolithiasis	0.0169	0.0317	CcSEcCtD
Pramipexole—Arrhythmia supraventricular—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0233	CcSEcCtD
Pramipexole—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00985	0.0185	CcSEcCtD
Pramipexole—Joint swelling—Hydrochlorothiazide—nephrolithiasis	0.00985	0.0185	CcSEcCtD
Pramipexole—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00862	0.0161	CcSEcCtD
Pramipexole—Toothache—Hydrochlorothiazide—nephrolithiasis	0.00794	0.0149	CcSEcCtD
Pramipexole—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.00761	0.0142	CcSEcCtD
Pramipexole—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0067	0.0126	CcSEcCtD
Pramipexole—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00631	0.0118	CcSEcCtD
Pramipexole—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.00616	0.0115	CcSEcCtD
Pramipexole—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.00616	0.0115	CcSEcCtD
Pramipexole—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00596	0.0112	CcSEcCtD
Pramipexole—HTR2A—urine—nephrolithiasis	0.00584	0.084	CbGeAlD
Pramipexole—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.00546	0.0102	CcSEcCtD
Pramipexole—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00539	0.0101	CcSEcCtD
Pramipexole—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00535	0.01	CcSEcCtD
Pramipexole—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00976	CcSEcCtD
Pramipexole—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00976	CcSEcCtD
Pramipexole—Gout—Hydrochlorothiazide—nephrolithiasis	0.00517	0.00969	CcSEcCtD
Pramipexole—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00511	0.00957	CcSEcCtD
Pramipexole—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00504	0.00945	CcSEcCtD
Pramipexole—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00492	0.00922	CcSEcCtD
Pramipexole—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00492	0.00922	CcSEcCtD
Pramipexole—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.00489	0.00916	CcSEcCtD
Pramipexole—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.00469	0.00879	CcSEcCtD
Pramipexole—SLC22A2—nephron tubule—nephrolithiasis	0.00452	0.0651	CbGeAlD
Pramipexole—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00442	0.00827	CcSEcCtD
Pramipexole—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00437	0.00818	CcSEcCtD
Pramipexole—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0043	0.00806	CcSEcCtD
Pramipexole—SLC22A2—renal system—nephrolithiasis	0.00411	0.0591	CbGeAlD
Pramipexole—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00405	0.00759	CcSEcCtD
Pramipexole—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00403	0.00755	CcSEcCtD
Pramipexole—SLC22A2—kidney—nephrolithiasis	0.00397	0.0572	CbGeAlD
Pramipexole—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00396	0.00741	CcSEcCtD
Pramipexole—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00734	CcSEcCtD
Pramipexole—SLC22A2—cortex of kidney—nephrolithiasis	0.00387	0.0557	CbGeAlD
Pramipexole—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00385	0.00721	CcSEcCtD
Pramipexole—Injury—Hydrochlorothiazide—nephrolithiasis	0.00382	0.00715	CcSEcCtD
Pramipexole—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00378	0.00708	CcSEcCtD
Pramipexole—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00375	0.00702	CcSEcCtD
Pramipexole—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00373	0.00699	CcSEcCtD
Pramipexole—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00372	0.00696	CcSEcCtD
Pramipexole—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0037	0.00693	CcSEcCtD
Pramipexole—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0037	0.00693	CcSEcCtD
Pramipexole—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00369	0.0069	CcSEcCtD
Pramipexole—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00369	0.0069	CcSEcCtD
Pramipexole—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00364	0.00682	CcSEcCtD
Pramipexole—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00361	0.00676	CcSEcCtD
Pramipexole—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00352	0.0066	CcSEcCtD
Pramipexole—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00351	0.00657	CcSEcCtD
Pramipexole—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00351	0.00657	CcSEcCtD
Pramipexole—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00348	0.00652	CcSEcCtD
Pramipexole—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00345	0.00647	CcSEcCtD
Pramipexole—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00345	0.00647	CcSEcCtD
Pramipexole—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00339	0.00634	CcSEcCtD
Pramipexole—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00332	0.00622	CcSEcCtD
Pramipexole—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00618	CcSEcCtD
Pramipexole—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00322	0.00602	CcSEcCtD
Pramipexole—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0032	0.006	CcSEcCtD
Pramipexole—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.0032	0.006	CcSEcCtD
Pramipexole—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00319	0.00598	CcSEcCtD
Pramipexole—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00317	0.00594	CcSEcCtD
Pramipexole—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00316	0.00592	CcSEcCtD
Pramipexole—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00581	CcSEcCtD
Pramipexole—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00309	0.00579	CcSEcCtD
Pramipexole—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00305	0.00572	CcSEcCtD
Pramipexole—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00303	0.00568	CcSEcCtD
Pramipexole—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00303	0.00568	CcSEcCtD
Pramipexole—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00297	0.00557	CcSEcCtD
Pramipexole—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00295	0.00553	CcSEcCtD
Pramipexole—SLC22A1—renal system—nephrolithiasis	0.0029	0.0418	CbGeAlD
Pramipexole—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00283	0.00531	CcSEcCtD
Pramipexole—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00282	0.00528	CcSEcCtD
Pramipexole—SLC22A1—kidney—nephrolithiasis	0.00281	0.0404	CbGeAlD
Pramipexole—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0028	0.00525	CcSEcCtD
Pramipexole—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00279	0.00523	CcSEcCtD
Pramipexole—HTR1D—kidney—nephrolithiasis	0.00278	0.04	CbGeAlD
Pramipexole—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00277	0.00518	CcSEcCtD
Pramipexole—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00276	0.00517	CcSEcCtD
Pramipexole—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00273	0.00512	CcSEcCtD
Pramipexole—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00272	0.00509	CcSEcCtD
Pramipexole—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00266	0.00499	CcSEcCtD
Pramipexole—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00266	0.00498	CcSEcCtD
Pramipexole—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00265	0.00496	CcSEcCtD
Pramipexole—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00265	0.00496	CcSEcCtD
Pramipexole—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00263	0.00492	CcSEcCtD
Pramipexole—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00263	0.00492	CcSEcCtD
Pramipexole—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00259	0.00485	CcSEcCtD
Pramipexole—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00258	0.00483	CcSEcCtD
Pramipexole—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00255	0.00478	CcSEcCtD
Pramipexole—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00254	0.00475	CcSEcCtD
Pramipexole—HTR2B—cortex of kidney—nephrolithiasis	0.00252	0.0363	CbGeAlD
Pramipexole—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00247	0.00463	CcSEcCtD
Pramipexole—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00243	0.00456	CcSEcCtD
Pramipexole—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00241	0.00452	CcSEcCtD
Pramipexole—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00241	0.00451	CcSEcCtD
Pramipexole—HTR1A—renal system—nephrolithiasis	0.0024	0.0345	CbGeAlD
Pramipexole—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00239	0.00448	CcSEcCtD
Pramipexole—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00234	0.00438	CcSEcCtD
Pramipexole—ADRA2C—nephron tubule—nephrolithiasis	0.00232	0.0333	CbGeAlD
Pramipexole—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00226	0.00424	CcSEcCtD
Pramipexole—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00225	0.00422	CcSEcCtD
Pramipexole—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00214	0.00402	CcSEcCtD
Pramipexole—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00211	0.00396	CcSEcCtD
Pramipexole—ADRA2C—renal system—nephrolithiasis	0.00211	0.0303	CbGeAlD
Pramipexole—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00208	0.0039	CcSEcCtD
Pramipexole—Tension—Hydrochlorothiazide—nephrolithiasis	0.00207	0.00388	CcSEcCtD
Pramipexole—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00207	0.00387	CcSEcCtD
Pramipexole—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00205	0.00384	CcSEcCtD
Pramipexole—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00204	0.00383	CcSEcCtD
Pramipexole—ADRA2C—kidney—nephrolithiasis	0.00204	0.0293	CbGeAlD
Pramipexole—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00203	0.0038	CcSEcCtD
Pramipexole—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00199	0.00373	CcSEcCtD
Pramipexole—ADRA2C—cortex of kidney—nephrolithiasis	0.00198	0.0285	CbGeAlD
Pramipexole—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00198	0.00371	CcSEcCtD
Pramipexole—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00196	0.00367	CcSEcCtD
Pramipexole—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00195	0.00366	CcSEcCtD
Pramipexole—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00194	0.00364	CcSEcCtD
Pramipexole—Malaise—Hydrochlorothiazide—nephrolithiasis	0.0019	0.00357	CcSEcCtD
Pramipexole—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0019	0.00355	CcSEcCtD
Pramipexole—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00189	0.00355	CcSEcCtD
Pramipexole—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00189	0.00354	CcSEcCtD
Pramipexole—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00187	0.0035	CcSEcCtD
Pramipexole—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00186	0.00348	CcSEcCtD
Pramipexole—Cough—Hydrochlorothiazide—nephrolithiasis	0.00184	0.00345	CcSEcCtD
Pramipexole—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00337	CcSEcCtD
Pramipexole—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00337	CcSEcCtD
Pramipexole—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00337	CcSEcCtD
Pramipexole—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00179	0.00336	CcSEcCtD
Pramipexole—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00178	0.00333	CcSEcCtD
Pramipexole—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00176	0.00329	CcSEcCtD
Pramipexole—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00174	0.00326	CcSEcCtD
Pramipexole—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00172	0.00323	CcSEcCtD
Pramipexole—Shock—Hydrochlorothiazide—nephrolithiasis	0.0017	0.00318	CcSEcCtD
Pramipexole—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00169	0.00316	CcSEcCtD
Pramipexole—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00168	0.00315	CcSEcCtD
Pramipexole—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00167	0.00312	CcSEcCtD
Pramipexole—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00164	0.00308	CcSEcCtD
Pramipexole—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00161	0.00302	CcSEcCtD
Pramipexole—ADRA2A—cortex of kidney—nephrolithiasis	0.00158	0.0228	CbGeAlD
Pramipexole—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00157	0.00294	CcSEcCtD
Pramipexole—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00156	0.00292	CcSEcCtD
Pramipexole—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00155	0.0029	CcSEcCtD
Pramipexole—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00154	0.00288	CcSEcCtD
Pramipexole—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00153	0.00287	CcSEcCtD
Pramipexole—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00152	0.00284	CcSEcCtD
Pramipexole—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0015	0.00281	CcSEcCtD
Pramipexole—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00149	0.00278	CcSEcCtD
Pramipexole—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00147	0.00276	CcSEcCtD
Pramipexole—Pain—Hydrochlorothiazide—nephrolithiasis	0.00147	0.00276	CcSEcCtD
Pramipexole—HTR2A—renal system—nephrolithiasis	0.00143	0.0206	CbGeAlD
Pramipexole—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00142	0.00266	CcSEcCtD
Pramipexole—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00141	0.00264	CcSEcCtD
Pramipexole—HTR2A—kidney—nephrolithiasis	0.00138	0.0199	CbGeAlD
Pramipexole—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00137	0.00257	CcSEcCtD
Pramipexole—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00136	0.00255	CcSEcCtD
Pramipexole—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00136	0.00255	CcSEcCtD
Pramipexole—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00127	0.00238	CcSEcCtD
Pramipexole—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00124	0.00232	CcSEcCtD
Pramipexole—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00122	0.00228	CcSEcCtD
Pramipexole—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00118	0.00221	CcSEcCtD
Pramipexole—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00114	0.00214	CcSEcCtD
Pramipexole—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0011	0.00205	CcSEcCtD
Pramipexole—Rash—Hydrochlorothiazide—nephrolithiasis	0.00109	0.00204	CcSEcCtD
Pramipexole—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00109	0.00203	CcSEcCtD
Pramipexole—Headache—Hydrochlorothiazide—nephrolithiasis	0.00108	0.00202	CcSEcCtD
Pramipexole—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00102	0.00192	CcSEcCtD
Pramipexole—SLC22A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000667	0.00168	CbGpPWpGaD
Pramipexole—DRD4—GPCR ligand binding—PTH—nephrolithiasis	0.000659	0.00166	CbGpPWpGaD
Pramipexole—DRD1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000649	0.00164	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000645	0.00163	CbGpPWpGaD
Pramipexole—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000643	0.00162	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—RGS14—nephrolithiasis	0.000642	0.00162	CbGpPWpGaD
Pramipexole—DRD3—GPCR ligand binding—CHRM3—nephrolithiasis	0.00064	0.00161	CbGpPWpGaD
Pramipexole—HTR2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000633	0.0016	CbGpPWpGaD
Pramipexole—HTR2B—GPCR ligand binding—PTH—nephrolithiasis	0.000629	0.00159	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—RGS14—nephrolithiasis	0.000625	0.00157	CbGpPWpGaD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000621	0.00157	CbGpPWpGaD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000621	0.00157	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—RGS14—nephrolithiasis	0.000607	0.00153	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—RGS14—nephrolithiasis	0.000606	0.00153	CbGpPWpGaD
Pramipexole—SLC22A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000594	0.0015	CbGpPWpGaD
Pramipexole—SLC22A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000594	0.0015	CbGpPWpGaD
Pramipexole—DRD1—GPCR ligand binding—PTH—nephrolithiasis	0.000593	0.0015	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—RGS14—nephrolithiasis	0.000586	0.00148	CbGpPWpGaD
Pramipexole—DRD3—GPCR ligand binding—PTH—nephrolithiasis	0.000585	0.00148	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—DGKH—nephrolithiasis	0.000585	0.00147	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—RGS14—nephrolithiasis	0.000583	0.00147	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR ligand binding—CHRM3—nephrolithiasis	0.000578	0.00146	CbGpPWpGaD
Pramipexole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000576	0.00145	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000572	0.00144	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—RGS14—nephrolithiasis	0.000567	0.00143	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000567	0.00143	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—DGKH—nephrolithiasis	0.000563	0.00142	CbGpPWpGaD
Pramipexole—HTR1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000558	0.00141	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000558	0.00141	CbGpPWpGaD
Pramipexole—HTR2C—GPCR ligand binding—CHRM3—nephrolithiasis	0.000555	0.0014	CbGpPWpGaD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000554	0.0014	CbGpPWpGaD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000554	0.0014	CbGpPWpGaD
Pramipexole—DRD5—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000552	0.00139	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—ADCY10—nephrolithiasis	0.000546	0.00138	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—SLC7A9—nephrolithiasis	0.000542	0.00137	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—DGKH—nephrolithiasis	0.000542	0.00137	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR ligand binding—CHRM3—nephrolithiasis	0.00054	0.00136	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000538	0.00136	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—ADCY10—nephrolithiasis	0.000535	0.00135	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—DGKH—nephrolithiasis	0.000531	0.00134	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR ligand binding—PTH—nephrolithiasis	0.000528	0.00133	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—ADCY10—nephrolithiasis	0.000526	0.00133	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—DGKH—nephrolithiasis	0.00052	0.00131	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—RGS14—nephrolithiasis	0.000515	0.0013	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—DGKH—nephrolithiasis	0.000511	0.00129	CbGpPWpGaD
Pramipexole—HTR1A—GPCR ligand binding—PTH—nephrolithiasis	0.00051	0.00129	CbGpPWpGaD
Pramipexole—HTR2C—GPCR ligand binding—PTH—nephrolithiasis	0.000508	0.00128	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000507	0.00128	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000507	0.00128	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—RGS14—nephrolithiasis	0.000506	0.00128	CbGpPWpGaD
Pramipexole—DRD5—GPCR downstream signaling—PTH—nephrolithiasis	0.000505	0.00127	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—ADCY10—nephrolithiasis	0.000502	0.00127	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—CHRM3—nephrolithiasis	0.000501	0.00126	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—DGKH—nephrolithiasis	0.0005	0.00126	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR ligand binding—PTH—nephrolithiasis	0.000494	0.00124	CbGpPWpGaD
Pramipexole—DRD2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00049	0.00123	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—DGKH—nephrolithiasis	0.000488	0.00123	CbGpPWpGaD
Pramipexole—HTR2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000482	0.00121	CbGpPWpGaD
Pramipexole—SLC22A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000475	0.0012	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—ADCY10—nephrolithiasis	0.000474	0.00119	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—ADCY10—nephrolithiasis	0.000467	0.00118	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—RGS14—nephrolithiasis	0.000464	0.00117	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—RGS14—nephrolithiasis	0.000461	0.00116	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—DGKH—nephrolithiasis	0.00046	0.00116	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—PTH—nephrolithiasis	0.000458	0.00116	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—RGS14—nephrolithiasis	0.000455	0.00115	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—DGKH—nephrolithiasis	0.000454	0.00115	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000452	0.00114	CbGpPWpGaD
Pramipexole—DRD2—GPCR ligand binding—PTH—nephrolithiasis	0.000448	0.00113	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—RGS14—nephrolithiasis	0.000447	0.00113	CbGpPWpGaD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000443	0.00112	CbGpPWpGaD
Pramipexole—HTR2A—GPCR ligand binding—PTH—nephrolithiasis	0.000441	0.00111	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000438	0.00111	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000436	0.0011	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.000434	0.00109	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—RGS14—nephrolithiasis	0.000427	0.00108	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000423	0.00107	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.000422	0.00106	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ADCY10—nephrolithiasis	0.000422	0.00106	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000414	0.00104	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—GRHPR—nephrolithiasis	0.000412	0.00104	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—DGKH—nephrolithiasis	0.00041	0.00103	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—DGKH—nephrolithiasis	0.000409	0.00103	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000409	0.00103	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000407	0.00103	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000407	0.00103	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ADCY10—nephrolithiasis	0.000405	0.00102	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—RGS14—nephrolithiasis	0.000403	0.00102	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—PTH—nephrolithiasis	0.000401	0.00101	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—GRHPR—nephrolithiasis	0.000401	0.00101	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—RGS14—nephrolithiasis	0.000397	0.001	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—DGKH—nephrolithiasis	0.000396	0.000998	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ADCY10—nephrolithiasis	0.000394	0.000994	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—DGKH—nephrolithiasis	0.000394	0.000993	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000389	0.00098	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—PTH—nephrolithiasis	0.000387	0.000975	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—GRHPR—nephrolithiasis	0.000384	0.000968	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—CHRM3—nephrolithiasis	0.000384	0.000968	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—DGKH—nephrolithiasis	0.000383	0.000966	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000383	0.000965	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—PTH—nephrolithiasis	0.000378	0.000954	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000377	0.00095	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000376	0.000947	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—PTH—nephrolithiasis	0.000372	0.000939	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—CHRM3—nephrolithiasis	0.00037	0.000932	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—AGXT—nephrolithiasis	0.000367	0.000926	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000367	0.000924	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000362	0.000912	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—RGS14—nephrolithiasis	0.000359	0.000904	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	0.000358	0.000901	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—AGXT—nephrolithiasis	0.000357	0.0009	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—PTH—nephrolithiasis	0.000356	0.000896	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000353	0.00089	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ADCY10—nephrolithiasis	0.000352	0.000887	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—PTH—nephrolithiasis	0.000351	0.000885	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	0.000348	0.000876	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—RGS14—nephrolithiasis	0.000346	0.000873	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—RGS14—nephrolithiasis	0.000344	0.000869	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—PTH—nephrolithiasis	0.000344	0.000867	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000343	0.000864	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—AGXT—nephrolithiasis	0.000342	0.000863	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000342	0.000862	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—PTH—nephrolithiasis	0.000338	0.000853	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—PTH—nephrolithiasis	0.000335	0.000845	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—RGS14—nephrolithiasis	0.000335	0.000845	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000333	0.000839	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—PTH—nephrolithiasis	0.000331	0.000834	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—CHRM3—nephrolithiasis	0.000328	0.000828	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000327	0.000823	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—GRHPR—nephrolithiasis	0.000325	0.000821	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—PTH—nephrolithiasis	0.000323	0.000814	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.00032	0.000807	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000315	0.000795	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000314	0.000791	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000314	0.000791	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—DGKH—nephrolithiasis	0.000314	0.000791	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—APRT—nephrolithiasis	0.000312	0.000787	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—SLC26A1—nephrolithiasis	0.000312	0.000787	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000311	0.000785	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000307	0.000774	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—DGKH—nephrolithiasis	0.000307	0.000774	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000305	0.000769	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—PTH—nephrolithiasis	0.000304	0.000768	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—RGS14—nephrolithiasis	0.000304	0.000767	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—SLC26A1—nephrolithiasis	0.000304	0.000766	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—APRT—nephrolithiasis	0.000304	0.000766	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000302	0.000762	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—DGKH—nephrolithiasis	0.000302	0.000762	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—PTH—nephrolithiasis	0.0003	0.000757	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—RGS14—nephrolithiasis	0.000299	0.000754	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—PTH—nephrolithiasis	0.000299	0.000753	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000297	0.000748	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CHRM3—nephrolithiasis	0.000296	0.000746	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—APRT—nephrolithiasis	0.000291	0.000734	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—SLC26A1—nephrolithiasis	0.000291	0.000734	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—AGXT—nephrolithiasis	0.00029	0.000731	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000288	0.000727	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—DGKH—nephrolithiasis	0.000288	0.000727	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000288	0.000727	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—PTH—nephrolithiasis	0.000287	0.000723	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000286	0.000722	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—CHRM3—nephrolithiasis	0.000285	0.000718	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—PTH—nephrolithiasis	0.000279	0.000703	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—CHRM3—nephrolithiasis	0.000277	0.000698	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000277	0.000698	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000272	0.000687	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	0.000272	0.000686	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000272	0.000686	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—DGKH—nephrolithiasis	0.000272	0.000686	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—PTH—nephrolithiasis	0.000271	0.000684	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—PTH—nephrolithiasis	0.000271	0.000682	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—DGKH—nephrolithiasis	0.000268	0.000677	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000268	0.000677	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—PTH—nephrolithiasis	0.000262	0.00066	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—PTH—nephrolithiasis	0.00026	0.000657	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—PTH—nephrolithiasis	0.000253	0.000639	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	0.000253	0.000638	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000251	0.000634	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000249	0.000628	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000248	0.000625	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000247	0.000624	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—APRT—nephrolithiasis	0.000247	0.000622	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	0.000247	0.000622	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—DGKH—nephrolithiasis	0.000242	0.000611	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000242	0.000611	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—DGKH—nephrolithiasis	0.000234	0.00059	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000234	0.00059	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000233	0.000587	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—DGKH—nephrolithiasis	0.000233	0.000587	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—PTH—nephrolithiasis	0.00023	0.00058	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CHRM3—nephrolithiasis	0.000227	0.000572	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000227	0.000571	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000226	0.000571	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—DGKH—nephrolithiasis	0.000226	0.000571	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—PTH—nephrolithiasis	0.000226	0.00057	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000225	0.000567	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—AQP1—nephrolithiasis	0.000222	0.000561	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000222	0.00056	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CHRM3—nephrolithiasis	0.000218	0.000551	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—AQP1—nephrolithiasis	0.000216	0.000546	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CHRM3—nephrolithiasis	0.000209	0.000526	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—AQP1—nephrolithiasis	0.000207	0.000523	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—PTH—nephrolithiasis	0.000207	0.000523	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	0.000206	0.000519	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—DGKH—nephrolithiasis	0.000205	0.000518	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000205	0.000518	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—PTH—nephrolithiasis	0.000203	0.000512	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000202	0.000509	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—DGKH—nephrolithiasis	0.000202	0.000509	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—CHRM3—nephrolithiasis	0.000201	0.000507	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—PTH—nephrolithiasis	0.0002	0.000504	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CHRM3—nephrolithiasis	0.000197	0.000496	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—CHRM3—nephrolithiasis	0.000196	0.000493	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CHRM3—nephrolithiasis	0.000194	0.000489	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—PTH—nephrolithiasis	0.000191	0.000481	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—CHRM3—nephrolithiasis	0.000188	0.000473	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000184	0.000463	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	0.000184	0.000463	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—PTH—nephrolithiasis	0.00018	0.000453	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—PTH—nephrolithiasis	0.000177	0.000447	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—AQP1—nephrolithiasis	0.000176	0.000443	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CHRM3—nephrolithiasis	0.000175	0.000442	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000169	0.000426	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CHRM3—nephrolithiasis	0.000168	0.000424	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CHRM3—nephrolithiasis	0.000164	0.000413	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—PTH—nephrolithiasis	0.00016	0.000404	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CHRM3—nephrolithiasis	0.000159	0.000401	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—PTH—nephrolithiasis	0.000155	0.00039	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—PTH—nephrolithiasis	0.000154	0.000388	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—PTH—nephrolithiasis	0.00015	0.000377	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	0.000148	0.000374	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000146	0.000368	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—SPP1—nephrolithiasis	0.000136	0.000343	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PTH—nephrolithiasis	0.000136	0.000342	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PTH—nephrolithiasis	0.000134	0.000337	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000133	0.000335	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	0.000122	0.000306	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—SPP1—nephrolithiasis	0.000104	0.000262	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—SPP1—nephrolithiasis	0.000102	0.000257	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—SPP1—nephrolithiasis	0.0001	0.000253	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—SPP1—nephrolithiasis	9.57e-05	0.000241	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—SPP1—nephrolithiasis	9.03e-05	0.000228	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—SPP1—nephrolithiasis	8.91e-05	0.000225	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—SPP1—nephrolithiasis	8.04e-05	0.000203	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—SPP1—nephrolithiasis	7.76e-05	0.000196	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—SPP1—nephrolithiasis	7.72e-05	0.000195	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—SPP1—nephrolithiasis	7.51e-05	0.000189	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SPP1—nephrolithiasis	6.82e-05	0.000172	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SPP1—nephrolithiasis	6.71e-05	0.000169	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	6.1e-05	0.000154	CbGpPWpGaD
